Pharmaceutical Production News
-
Showcase
ARAI-2PAM Barda Procurement Award
Broomfield, Colorado, 10/3/2022. Aktiv Pharma Group (Aktiv) today announced a procurement contract award from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). Under this contract (number 75A50122C00082), awarded under the 2004 Project ...
-
Showcase
FDA Emerging Technology Program
Broomfield Colorado 6/16/2022. Aktiv Pharma Group (Aktiv) announced today the acceptance of its novel glass-free, film-based flexible primary drug container (PDC) technology for sterile injectables named ARCH, into the US Food and Drug Administration (FDA) Emerging Technology Program (ETP). The ETP is a collaborative effort which supports the FDA’s mission to facilitate modernization in ...
-
Showcase
Aktiv Pharma Group Receives Grant Funding to Develop Tranexamic Acid Autoinjector
Broomfield Colorado 6/25/2022. Aktiv Pharma Group (Aktiv) announced today a grant award from the U.S. Department of Defense (DOD) Defense Health Agency (DHA) Joint Program Committee 6/Combat Casualty Care Research Program (JPC-6/CCCRP) [1] for the continued development of a tranexamic acid (TXA) autoinjector, targeting proposed indications related to prehospital treatment of severe bleeding. ...
-
Showcase
Onapristone Extended Release: Safety Evaluation from Phase I–II Studies with an Emphasis on Hepatotoxicity
Introduction Anliprogestins have demonstrated promising activity against breast and gynecological cancers, but liver-related safety concerns limited the advancement of this therapeutic class. Onapristone is a full progesterone receptor antagonist originally developed as an oral contraceptive and later evaluated in phase II studies for metastatic breast cancer. Because of liver enzyme elevations ...
-
Showcase
Empatica and BARDA Join Forces to Validate Wearable System That Detects COVID-19 Before Symptoms Appear
BOSTON, June 19, 2020 /PRNewswire/ -- Digital healthcare company Empatica announces a pioneering new partnership with the Biomedical Advanced Research and Development Authority ("BARDA"), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services (HHS), to validate an early warning system for COVID-19 and other respiratory ...
-
Showcase
ALung Announces Commercial Development of its Breakthrough Next Generation Artificial Lung
PITTSBURGH–(BUSINESS WIRE)– April 4, 2020 – ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced the recent initiation of commercial development of its next generation artificial lung, which expands the Company’s focus on highly efficient gas ...
-
Showcase
Zeneo® Midazolam Earns The Orphan Drug Designation
The American Food and Drug Administration (FDA) has granted Orphan Drug Designation to ZENEO® Midazolam for the treatment of status epilepticus (epileptic seizure lasting longer than 5 minutes). The orphan designation for ZENEO® Midazolam improves Crossject’s international visibility and gives impetus to its current negotiations for partnerships with pharmaceutical laboratories. ...
By Crossject
-
top quality 2c-b cas 66142-81-2 whatsapp/telegram:+4407548722515
We are a professional pharmaceutical chemical factory,contact us for any question when you need. Whatsapp/Telegram:+4407548722515Email: info@typugroup.comApplication: research chemicalDelivery Time: within 2 daysPort: Beijing, Shanghai, Shenzhen, Hongkong etcPurity: 99%Package: 1kg/foil bag, 25kg/drumPayment: BITCOIN,WESTERN UNION, T/T, MONEY GRAMShipment: by sea or express (TNT, UPS, DHL, FEDEX, ...
By Typu group
-
factory price A-pvp cas 14530-33-7 whatsapp/telegram:+4407548722515
We are a professional pharmaceutical chemical factory,contact us for any question when you need. Whatsapp/Telegram:+4407548722515Email: info@typugroup.comApplication: research chemicalDelivery Time: within 2 daysPort: Beijing, Shanghai, Shenzhen, Hongkong etcPurity: 99%Package: 1kg/foil bag, 25kg/drumPayment: BITCOIN,WESTERN UNION, T/T, MONEY GRAMShipment: by sea or express (TNT, UPS, DHL, FEDEX, ...
By Typu group
-
Revolutionize Your Drug Preformulation Workflows with the Precellys Evolution Homogenizer!
In a recent study in the European Journal of Pharmaceutics and Biopharmaceutics, Jochem Alsenz and Elisabeth Haenel present Precellys® Evolution homogenizer with Cryolys Evolution, a patent cooling system, as a versatile tool for improving preformulation processes in drug development. The study highlights the various uses of Precellys® Evolution homogenizer with Cryolys Evolution, ...
-
CD Bioparticles Introduces New Polyolefin Family Polymers for Drug Delivery Applications
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has recently expanded its low PDI polymer portfolio and announces its new offering of Polyolefin Family polymers with a wide range of properties that make them well-suited for a variety of drug delivery applications. Low dispersion index polymers are polymeric compounds with low molecular weight ...
-
CD Formulation Unveils Hydrogel Microneedle Patch Technology to Increase Drug Loading Capacity
CD Formulation, a leading pharmaceutical contract service company, has recently unveiled groundbreaking hydrogel microneedle patch technology aiming at increase the drug loading capacity and enhance drug delivery efficiency. The new technology represents a significant advancement in the field of transdermal drug delivery. The hydrogel microneedle patch consists of a patch with tiny microneedles ...
-
CD Formulation Enables Efficacy Evaluation of Oral Thin Films: Ensuring Therapeutic Efficacy and Safety
A breakthrough in CD formulation has enabled researchers to evaluate the efficacy of oral thin films, ensuring both therapeutic efficacy and safety. This new development has the potential to revolutionize the way oral medications are tested and administered, leading to more precise and effective treatments for a wide range of medical conditions. The development of oral thin films has gained ...
-
Biopharma Stock News Bite - Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) Spikes on News Potential Treatment for Alcohol Use Disorder
Investorideas.com (www.investorideas.com) Biotech Stock News Bites - Adial Pharmaceuticals, Inc. (NASDAQ: ADIL), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders made the NASDAQ Top ten percentage gainers today on news. The stock is trading at $2.0050, up $0.8750, gaining +77.0925% on volume of over 8o ...
-
AI Stocks Targeting Opportunities in the Global Healthcare Market (OTCQB: AVAI) (NASDAQ: NVDA) (NYSE: DELL) (NASDAQ: OTRK)
Investorideas.com, a global news source and expert investing resource covering AI stocks issues a news snapshot looking at how AI plays a key role in the future of healthcare, featuring Avant Technologies, Inc. (OTCQB: AVAI), an artificial intelligence (AI) technology company specializing in creating and developing innovative and advanced AI infrastructure solutions. What is the opportunity for ...
-
CD Formulation Incorporates Phase Separation Method for Microsphere Production
In the ever-evolving field of pharmaceuticals, continuous innovation is key to developing new drug delivery systems that can improve patient outcomes and increase therapeutic efficacy. One such innovation is the use of phase separation technology for the production of microspheres, a method that has recently been incorporated into CD Formulation’s controlled-release drug delivery systems. ...
-
CD Formulation Offers Accurate and Reliable Impurity Determination for Biopharmaceutical Studies
CD Formulation, a company in the field of biopharmaceutical studies, is revolutionizing the way impurity determination is conducted in the industry. With the use of advanced technology and cutting-edge methodologies, CD Formulation offers accurate and reliable testing for a wide range of impurities, ensuring the safety and effectiveness of pharmaceutical products. The expertise in organic ...
-
Huateng Pharma Proudly Unveils Its New Product - Semaglutide Side Chains
Huateng Pharma, a distinguished provider of premium pharmaceutical intermediates, proudly unveils its latest breakthrough: Semaglutide Side Chain. This groundbreaking addition to Huateng Pharma's esteemed portfolio signifies a remarkable leap forward in pharmaceutical innovation, showcasing a diverse array of compounds including AEEA-AEEA (CAS NO.: 1143516-05-5), SNAC (CAS NO.: 203787-91-1), ...
-
ExcellGene and Capricorn Scientific Forge Strategic Partnership to Revolutionize Biopharmaceutical Production
ExcellGene, a renowned Swiss biologics CDMO specializing in complex protein manufacturing services, using standard CHO and HEK293 expression systems and Capricorn Scientific, a leading German manufacturer of high-quality cell culture products, have joined forces in a strategic partnership to elevate the field of biopharmaceutical ...
-
Alfa Chemistry Expands Selection of Click Chemistry Reagents: DBCO, BCN, and Tetrazines Included
Alfa Chemistry, a leading chemical supplier and service provider, has recently announced the expansion of their selection of click chemistry reagents. This development aims to better serve the needs of researchers and scientists working in the field of click chemistry, a powerful method for assembling complex molecular structures quickly and efficiently. Click chemistry has gained significant ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you